Five Chlamydia psittaci isolates (1 turkey, 1 psittacine, 1 human, and 2 pigeon isolates) failed to react with serovar-specific monoclonal antibodies to known avian and mammalian C. psittaci serovars and were presumed to represent 1 or more new serovars. The isolates were characterized using restriction endonuclease analysis of the whole genome, polymerase chain reaction-restriction fragment length polymorphism of the major outer membrane protein genome, monoclonal antibody comparisons, and growth in tissue culture. Monoclonal antibodies were produced to the human isolate (MP) and to the psittacine isolate (VS225). The monoclonal antibody results show that the isolates represent 2 new avian serovars (serovars E and F). The restriction fragment length polymorphism analysis of the major outer membrane protein genome demonstrated that the isolates are distinct. The whole genome restriction endonuclease analysis data and the growth patterns in tissue culture indicate that the new serovars are similar to avian serovars recognized previously. A subspecies monoclonal antibody that reacted with serovars A and B also reacted with serovar E, indicating that these serovars are closely related. The results show that these isolates represent 2 new avian serovars, making them the fifth and sixth avian serovars identified in North American birds.
nique. The technique is dependent on the selection of the restriction endonucleases used. A single nucleotide change can give a different pattern, although that change may have little or no effect on the antigenic epitopes to which the host responds. The PCR-RFLP technique is best used to show potential differences among isolates, whereas MAbs provide an actual measure of differences in antigenic epitopes, which may be important in vaccine development.
The goal of this research was to serotype 5 previously untyped C. psittaci isolates, which were found to represent 2 additional avian serovars.
Materials and methods
The origin of the C. psittaci isolates are given in Table 1 . The VS1, 3 CP3, 15 WWD, 8 GD, 10 CT1, 14 NJ1, 12 and TT3 13 isolates are representatives of previously identified avian serovars. The MP isolate is the Francis strain from the American Type Culture Collection (ATCC). The remaining 5 isolates are from the National Veterinary Services Laboratories and represent current field isolates. The Chlamydiae were adapted for growth in Vero cell monolayers in 25cm 2 tissue culture flasks. Chlamydial stocks for MAb production and DNA extraction were produced in 890-cm 2 roller bottles. Chlamydiae were harvested for use between the third and eighth passage in tissue culture.
Cell cultures. Vero cells were cultured in Eagle's minimum essential medium with Earle's balanced salts, 20 mmol of HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 5% fetal bovine serum/liter, 5.4 ml glucose/liter, 292 mg glutamine/liter, 2 µg amphotericin B/ml, and 10 µg gentamicin sulfate/ml. Cyclohexamide (0.5 µg/ml) was added to the medium following inoculation of the monolayers with chlamydiae. Vero cells used to study inclusion formation *ATCC = American Type Culture Collection, Rockville, MD; NVSL = National Veterinary Services Laboratories, USDA, APHIS, Ames, IA.
† MP has also been referred to as Francis, MN, or Cal-10 strain and is likely from exposure to pigeons.
were grown in 96-well dishes or on 12-mm-diameter coverslips in 24-well dishes. The monolayers were infected with 10-fold dilutions of chlamydiae to obtain concentrations that permitted viewing of the characteristic inclusions. The monolayers were fixed on days 1, 2, and 3 postinfection with a mixture of 50% methyl alcohol and 50% acetone. Chlamydial inclusions were stained by the indirect fluorescent antibody technique using a group-reactive or a serovar-specific MAb. 3 Production of hybridomas and MAbs. MAbs were produced to the MP and VS225 isolates of C. psittaci using the procedures reported previously. 3 BALB/c mice were immunized with purified Chlamydiae inactivated with ethylenimine. Cell fusion and cloning of the antibody-secreting hybridomas were accomplished using standard procedures. Hybridoma cell culture fluids were screened for antibody by the indirect immunofluorescence (IF) technique using confluent Vero cell monolayers infected with the homologous strain of C. psittaci. Clones that reacted at a 1:4 dilution were further tested against the VS1 (psittacine) strain and against representatives of other heterologous serotypes of C. psittaci to determine group reactivity. The clones selected as potentials for inclusion in the serotyping panel were recloned and retested prior to producing ascites fluids in mice. Serovar-specific MAbs to the other avian serovars were produced and are reported elsewhere. 2 Indirect microimmunofluorescence (IMIF) test. The IMIF test was performed essentially as previously described. 18 The chlamydial antigen was mixed with a normal yolk sac preparation and phosphate-buffered saline (PBS) to give the desired concentration of antigen and yolk sac. The antigen was placed in 0.4.-µl dots on a standard microscope slide. The slides were allowed to air dry for 30 min and then fixed with acetone for 10 min. Two microliters of the MAbs at the proper dilution were added to each dot. The slides were then incubated for 30 min in a humidified chamber at 37 C, after which they were washed 3 times with PBS and 3 times with distilled water. The slides were air dried after removing excess moisture by careful aspiration. The slides were then stained with fluorescein-conjugated anti-mouse IgG serum at a dilution of 1:60 containing 0.05% Evans blue. The staining was done by adding 3 µl of the fluorescein-conjugated anti-mouse serum to each dot. The slides were then incubated, washed, and dried as described above. Coverslips were mounted on the slides using a glycerol/PBS buffer mounting fluid. The slides were read with an epifluorescence microscope equipped with 10 x dry, 40 x dry, and 60 x oil objectives.
The antigen dots were placed on the slide using a pattern of 4 rows of 7 dots each. The dots were spaced 5 mm apart to facilitate viewing with a microscope. This permitted the use of 4 dilutions for each of the 7 MAbs on 1 microscope slide. The first column of 4 wells was used for a group-reactive MAb. The remaining columns were used to test the sample with serovar-specific MAbs at dilutions of 1:100, 1:400, 1:1,600, and 1:6,400. The MAbs are identified and their specificities given in Table 2 . In addition, the serovar-specific MAbs to the new serovars were tested against the following mammalian strains: B577 (ovine abortion), IPA (ovine polyarthritis), FP (feline pneumonitis), GPIC (Guinea pig inclusion conjunctivitis), M56 (muskrat), WC (bovine), BP 1 (bovine respiratory), and Z (bovine respiratory). An isolate was identified as a particular serotype if reactions were observed at 1:1,600 to 1:6,400 with 1 MAb and no reactions at 1:100 with the remaining serovar-specific MAbs. Isolates that reacted with the group-reactive MAb and not with any of the serovar-specific MAbs were presumed to be members of a currently unidentified serovar.
Restriction endonuclease digestion of DNA. High molecular weight chromosomal DNA was prepared following purification and concentration of the Chlamydial harvest as previously described. 1 The DNA was digested in 1-2-µg amounts in a 40-µl volume with 5-10 units of enzyme for 3-4 hr under conditions recommended by the manufacturer. The samples were electrophoresed on a 16-x 30-cm gel at 60 V for 16 hr on a horizontal electrophoresis box. The electrophoresis gel was made up of 0.6% agarose in Tris borate buffer. The gels were stained in ethidium bromide for 60 min, washed in PBS, and photographed under short-wave UV light through a Kodak 23A red filter. Three restriction enzymes (BamHI, PstI, and EcoRI) were used in the study.
PCR-RFLP analysis of the MOMP gene. The PCR procedure was performed essentially as described. 4 The chlamydial samples were either tissue culture or egg yolk sac harvest. The oligonucleotide primers CTU/CTL (CTU: 5'-ATGAAAAAACTCTTAAATCGG-3'; CTL: 5'-CAA-GATTTTCTAGA(T/C)TTCAT(C/T)TTGTT-3') are from a highly conserved region of the MOMP gene. Samples were subjected to 30 cycles of amplification in a DNA thermal cycler under the following conditions: denaturation, 1 min at 95 C; primer annealing, 1 min at 51 C; and primer extension, 2 min at 72 C. After completion of the 30 cycles, a primer extension at 72 C for 7 min was used. The primers allow amplification of an approximately 1.1-kb fragment. To assess the amplification, a 5-µl volume of the PCR product was electrophoresed on a 1.5% agarose gel, a stained with ethidium bromide, and photographed under UV illumination. Restriction endonuclease digestion with AluI was performed on a 35-µl sample of the amplified DNA. Seven microliters of the digest was subjected to electrophoresis on a 4.0% agarose ge1. a
Results
The 5 C. psittaci isolates failed to react with the serovar-specific monoclonal antibodies (MAbs) in our serotyping panel. The panel included MAbs to 4 avian serovars (serovars A-D) ( Table 2 ) and 8 mammalian serovars (B577, IPA, FP, GPIC, M56, WC, BP1, Z). Preliminary whole genome restriction endonuclease and PCR-RFLP analyses indicated that the human isolate MP and the avian isolates P24, VS24, and VS177 were similar to 1 another and that the VS225 isolate was different. MAbs were produced to the human isolate MP and to the avian isolate VS225. One serovar-specific MAb to MP (MAb MP/A4) and 1 serovar-specific MAb to VS225 (MAb VS225/05) were selected for use in the remaining studies. Both MAbs gave strong reactions in the IMIF test at 1:6,400 dilutions with the homologous strain and no cross-reactions with other known avian and mammalian serovars of C. psittaci at a 1:25 dilution.
The IMIF test reactions of the 2 selected MAbs and the serovar-specific MAbs to the avian serovars A-F, a subspecies MAb (VS1/F9), and a genus-specific MAb are given in Table 3 . Each of the serovar-specific MAbs was specific to the homologous isolate, giving a positive reaction at ≥ 1:1,600 without giving a reaction at ≥ 1:100 with isolates of other serovars. The subspeciesspecific MAb (VS1/F9) reacted with the VS1, CP3, and MP strains representing serovars A, B, and E, respectively.
The isolates were tested for similarities with other avian isolates by restriction endonuclease analysis (REA) of the whole chromosomal DNA. Four of the isolates (VS24, P24, MP, VS225) were compared using EcoRI, PstI, and BamHI enzymes. Results with EcoRI are shown in Fig. 1 . The DNA digest patterns of the VS24, P24, and MP isolates are similar to the digest patterns of the 2 serovar A isolates (WWD, CP3). A few band differences were noted with the remaining avian isolates tested. The DNA digest pattern of the VS225 isolate was only 1 or 2 bands different from most of the other avian isolates.
Representatives of each of the 4 known avian serovars (serovars A-D) and of the MP isolate and the VS225 isolate were compared using AluI restriction endonuclease digests of PCR products of the MOMP genome (Fig. 2) . The results show that each gave a distinct pattern. PCR-RFLP AluI restriction endonuclease digests of VS24, P24, and VS177 gave digest patterns similar to that of the MP isolate (data not shown).
The growth rate and inclusion morphology in Vero cells and McCoy cells for the VS24, VS177, P24, MP, and VS225 isolates were characteristic of avian isolates. Large, dense, intensely staining, crescent-shaped inclusions were seen at 24 hours; these inclusions were often wrapped around the nuclei of cells. Infections progressed to Cytopathic effect at 48-72 hours.
Discussion
The 5 C. psittaci isolates represent 2 additional avian serovars. The human isolate MP, the 2 pigeon isolates VS177 and P24, and the turkey isolate VS24 represent a single new serovar. This new serovar is here designated serovar E. The VS225 isolate from a psittacine bird is here designated serovar F. These and the 4 previously known avian serovars 2,17 make 6 known avian serovars of C. psittaci present in North America (Table 2) . Serovar E, represented by the human MP isolate, is of interest because it was originally isolated in 1934 from a human with influenza symptoms and has been widely used in laboratories. The origin of the isolate has always been in question because most researchers Figure 2 . AluI digestion products of PCR-amplified major outer membrane protein genome for selected avian isolates representing serovars A-F. Fragments were separated on a 4% low-melting-point agarose gel and stained with ethidium bromide. Lane labels correspond with chlamydial strains used for MAb production.
felt it was not a typical human strain and because the original laboratory isolation was made in a ferret. There are also some indications in the literature that more than 1 isolate was made at this time and that they were all considered the same; consequently, laboratories may have been sent different isolates. These isolates have been labeled the MN, MP, Cal 10, and Francis strains and are often considered identical. In this study, the isolate was from the ATCC collection. Isolates from other laboratories have been tested with varying results, so researchers must be cautious when using this strain.
Currently, pigeons appear to be the natural host of this new serovar E. This conclusion is supported by the close serologic relation of the serovar E isolates to serovar A and serovar B. Two of the isolates came directly from pigeons found in different areas of the country and in different years. It is reasonable to suppose that the turkey isolate came from an infection acquired from a pigeon, because pigeons are known to frequent turkey sheds. The human isolate could also be from a human infection acquired from a pigeon. A number of isolates from rheas and ostriches have been of serotype E. Again, the pigeon or dove source cannot be discounted, because it is known that the strain has been in North America for years and was not introduced by ratites. Because of these factors, serovar E is considered primarily of pigeon origin.
The second new serovar, F, represented by the VS225 isolate, appears to be a chance isolate; isolates of that serovar have not been reported previously. The isolate was from a parakeet in Texas. Its PCR-RFLP pattern and MAb reaction pattern distinguish it from any of our isolates and from any isolates evaluated in Europe 16, 17 The REA of the whole chromosomal DNA . clearly shows that serovar F is similar to other avian isolates and is distinct from mammalian iso1ates. 1 The isolate can represent a serovar that is rare in the avian population, that is newly mutated, or that resides in an avian species that has not been examined for chlamydia.
MAbs and PCR-RFLP, using the restriction enzyme AluI, were used in this study to prove that the isolates represent 2 new strains of C. psittaci. Both of these tests measure changes in the MOMP, which makes up some 60% of the Chlamydial outer membrane protein mass. Some serovar-specific MAbs that neutralize infectivity are directed to a trimer of the MOMP. 11 Most other serovar-specific MAbs are thought to be directed to this protein even though most will not react on western blot analysis. The PCR-RFLP is directed toward detecting changes in the MOMP genome. The AluI restriction enzyme digest of the PCR-amplified genome has been a reliable and useful method of measuring these changes because it correlates well with serologic results. Other restriction enzymes have been used for typing C. trachomatis and C. psittaci. 5, 16 The value of some of these enzymes for typing is questionable because the changes detected in the MOMP genome have not been correlated with serologic or functional changes.
The chlamydial strains isolated in the USA are usually of serovars A, B, D, or E. Other serovars may be present and not identified; it takes both an avian species that is highly visible and a chlamydial strain that produces disease or death of the host before isolation attempts for chlamydiae are made. Serovar-host relationships are common. Serovar A is usually isolated from psittacine birds, and serovar B is commonly isolated from pigeons. Serovar D is the strain isolated from most outbreaks where humans have become infected. It has also been isolated from gulls near an outbreak in turkeys; 20 the reservoir is not known. Serovars B and E have also been recovered from turkeys. Serovar E appears to be of pigeon origin; it includes approximately 20% of the pigeon isolates. However, it also includes a significant number of the isolates from ratites and may be particularly virulent for ratites. The remaining serovars, C and F, each have been identified only once in the USA. Serovar C may be of significance in ducks and geese in Europe. 17 a. FMC BioProducts, Rockland, ME.
